Search

everythinglearnresearchcommunity

for

Search:↓

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Letrozole may help prevent seizures by reducing certain hormone levels.

New compounds show promise as nonsteroidal treatments for hair loss.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Finasteride may help prevent prostate cancer.

Ocimum basilicum L. and red Oryza sativa L. may help with hair loss and prostate issues.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

5α-reductase inhibitors help manage symptoms of benign prostatic hyperplasia and may also prevent prostate cancer and treat hair loss.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

TGF-β inhibitors may help treat liver fibrosis by targeting various pathways.